Bosnia and Herzegovina vs Bulgaria: Proportion of women aged 15-49 years with anaemia, non-pregnant
Bosnia and Herzegovina
26.0%
in 2023
Bulgaria
25.8%
in 2023
Bosnia and Herzegovina rank
97th
Bulgaria rank
99th
Proportion of women aged 15-49 years with anaemia, non-pregnant over time
- Bosnia and Herzegovina
- Bulgaria
How they compare
Bosnia and Herzegovina currently reports 26.0% against 25.8% in Bulgaria, a difference of 0.2%.
Across all 24 years both countries report, Bosnia and Herzegovina has been ahead every year.
Bosnia and Herzegovina ranks 97th and Bulgaria ranks 99th of 209 countries.
Bosnia and Herzegovina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Bulgaria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.8% | 21.5% | 0.3% | Bosnia and Herzegovina |
| 2010s | 22.5% | 22.1% | 0.4% | Bosnia and Herzegovina |
| 2020s | 25.0% | 24.8% | 0.2% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of women aged 15-49 years with anaemia, non-pregnant, Bosnia and Herzegovina or Bulgaria?
- Bosnia and Herzegovina, at 26.0% against 25.8% in Bulgaria as of 2023.
- What is the difference in proportion of women aged 15-49 years with anaemia, non-pregnant between Bosnia and Herzegovina and Bulgaria?
- 0.2%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Bulgaria?
- 24 years are reported by both, from 2000 to 2023.
- How do Bosnia and Herzegovina and Bulgaria rank globally for proportion of women aged 15-49 years with anaemia, non-pregnant?
- Bosnia and Herzegovina ranks 97th and Bulgaria ranks 99th of 209 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of women aged 15-49 years with anaemia, non-pregnant (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.